Publication | Open Access

Mutations in Specific Codons of the KRAS Oncogene are Associated with Variable Resistance to Neoadjuvant Chemoradiation Therapy in Patients with Rectal Adenocarcinoma

Somatic VariantKras OncogeneTumor HeterogeneityMedicineOncogenic AgentPathologyVariable ResistanceSpecific CodonsCancer GeneticsOncologyRadiation OncologyHealth Sciences